Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
11/2002
11/28/2002US20020177712 Process to prepare clopidogrel
11/28/2002US20020177707 Aminoaryl oxazolidinone n-oxides
11/28/2002US20020177578 3-hydroxy-4-methoxypyridine-2-carboxyamides N-substituted with a benzyl 9-member dilactone ring
11/28/2002CA2447465A1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d]pyrimidine for the treatment of pain
11/28/2002CA2447063A1 Novel use
11/27/2002EP1260512A1 Novel cyclic amide derivatives
11/27/2002EP1259515A2 Thienopyridine derivatives and their use as anti-inflammatory agents
11/27/2002EP1259510A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
11/27/2002EP1259229A2 Use of pde v inhibitors
11/27/2002EP0915093B1 Amide derivatives
11/27/2002EP0825982B1 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/27/2002CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002CN1382125A Bicycle vasporession agonists
11/26/2002US6486199 Spiro and dispiro 1,2,4-trioxolane antimalarials
11/26/2002US6486171 Useful in the treatment of some central nervous system disorders including as an antidepressant; 4-(1-(2-naphthyl)ethyl)-4- piperidinyl)thieno(3,2-c)pyridine, for example
11/26/2002US6486163 Thienopyranecarboxamide derivatives
11/26/2002US6485984 Calixcrown derivatives, a process for the preparation thereof, a self-assembled mono-layer of the calixcrown derivatives prepared by using the same and a process for immobilizing a protein mono-layer by using the self-assembled mono-layer of the calixcrown derivatives
11/26/2002US6485941 Inhibition of the carboxyltransferase component of acetyl-CoA carboxylase, and the use of such inhibition in anti-cancer and anti-lipogenic therapies
11/26/2002CA2102889C Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use
11/22/2002WO2001090079A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
11/22/2002CA2410304A1 Novel carbamates and ureas production and use thereof as endothelin receptor antagonists
11/21/2002WO2002092594A1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002WO2002092564A2 Synthesis of cyclopentadiene derivatives
11/21/2002WO2002092563A2 Protease inhibitors
11/21/2002WO2002092076A1 Substituted coumarins and quinolines as caspases activators
11/21/2002WO2002062343A3 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/21/2002WO2002049649A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
11/21/2002US20020173445 Selective androgen receptor modulators and methods for their identification, design and use
11/20/2002EP1257550A1 Platelet adp receptor inhibitors
11/20/2002EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/20/2002CN1094490C Quinolein-2(1H)-one derivativs as serotonin antagonists
11/19/2002US6482948 Thienopyrimidine compounds and salts thereof and process for the preparation of the same
11/18/2002WO2001087855A1 Triazole derivatives
11/14/2002WO2002090342A1 Chromene compound
11/14/2002WO2002090319A1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
11/14/2002WO2002072089A3 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof
11/14/2002WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002US20020169178 Benzothieno[3,2-c]pyridines as alpha2 antagonists
11/14/2002US20020169155 A nitrogen-ring containing triheterocyclic compound is useful for treating a disease associated with aberrant leukocyte recruitment and/or activation
11/13/2002EP1256581A1 Preventive or therapeutic agents for gastric or esophageal regurgitation
11/13/2002EP1256576A1 Fused imidazolium derivatives
11/13/2002EP1056451B1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
11/13/2002EP0989131B1 Thienotriazolodiazepine compounds and medicinal uses thereof
11/13/2002EP0846119B1 Thienopyrimidine derivatives, their production and use as endothelin antagonists
11/13/2002CN1379761A Condensed indoline derivatives and their use as 5HT, in particular 5HT2C receptor ligands
11/12/2002US6479674 Carboxylic acid derivatives and process for producing same
11/12/2002US6479527 Bicyclic pyrrole derivatives as MCP-1 inhibitors
11/12/2002US6479512 Tyrosine kinase inhibitors
11/12/2002US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002US6479489 Substituted spiroheterocyclic 1H-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
11/12/2002CA2246839C Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
11/12/2002CA2068083C Anti-bacterial compound
11/07/2002WO2002088138A1 Novel 4-amino-5,6-substituted thiopheno[2,3-d]pyrimidines
11/07/2002WO2002087584A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002US20020165398 Amino-thiophene-amido derivatives
11/07/2002US20020165365 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same
11/07/2002US20020165230 Gamma-ketoacid dipeptides as inhibitors of caspase-3
11/07/2002US20020165225 Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
11/07/2002US20020164649 Mass tags for quantitative analysis
11/07/2002CA2445871A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/06/2002EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002EP0993459B1 Compounds useful for inhibition of farnesyl protein transferase
11/06/2002EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002EP0812192B1 Benzothiopyranoindazoles antitumor agents
11/06/2002CN1378542A FAB I inhibitors
11/06/2002CN1093856C Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
11/05/2002US6476047 Good bioavailability and powerful analgesic activity based on calcium channel blockade.
11/05/2002US6476022 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods
11/05/2002US6476018 Fused imidazole derivatives as multidrug resistance modulators
10/2002
10/31/2002WO2002085413A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same
10/31/2002WO2002041896A3 Use of thienopyrimidines
10/31/2002WO2002028874A3 Tumor proliferation inhibitors
10/31/2002WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002US20020161228 Piperidine compounds
10/31/2002US20020161034 Spiro-pyran compounds; use as pesticides and herbicides
10/31/2002US20020161008 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression
10/31/2002US20020161005 Nitrogen heterocycle compounds
10/31/2002US20020160984 For example, 2,3-dihydro-1H-benz(de)isoquinolin-1-one; treating diabetes, cancer, radiosensitizing tumor cells, cardiovascular disorders, septic shock, inflammatory bowel disease, senescent cells
10/31/2002US20020160282 Nonlinear response; electrical communication; mixture of thiophene compound in polymer matrix
10/30/2002EP1252133A2 Pharmaceutical compounds
10/30/2002EP0831835B1 Treating anorexia
10/30/2002CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002CN1377271A Use of thienopyrimidines
10/29/2002US6472530 Benzo-fused dithiepino[6,5-b]pyridines, and related compositions and methods
10/29/2002US6472419 1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents
10/29/2002US6472418 Non-peptide NK1 receptors antagonists
10/29/2002CA2036618C Fused thiophene derivatives, their production and use
10/24/2002WO2002083685A1 Cyclohexylphenyl vasopressin agonists
10/24/2002WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002WO2002083145A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002WO2002083111A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
10/24/2002WO2002083083A2 Pharmaceutically active compounds and methods of use
10/24/2002WO2002051848A3 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
10/24/2002WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002WO2002038540A3 Activity-dependent cysteine protease profiling reagent
10/24/2002WO2002014305A3 Design and synthesis of advanced nlo materials for electro-optic applications
10/24/2002US20020156299 Novel carboxylic acid derivatives and process for producing the same
10/24/2002US20020156076 Imidazole derivatives used to reduce ocular pressure or treat glaucoma and other diseases
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 214